Endothelial Galectin-1 Binds to Specific Glycans on Nipah Virus Fusion Protein and Inhibits Maturation, Mobility, and Function to Block Syncytia Formation: e1000993

• Published in: PLoS pathogens 2010-07, Vol.6 (7)
• Main Authors: Garner, Omai B, Aguilar, Hector C, Fulcher, Jennifer A, Levroney, Ernest L, Harrison, Rebecca, Wright, Lacey, Robinson, Lindsey R, Aspericueta, Vanessa, Panico, Maria, Haslam, Stuart M, Morris, Howard R, Dell, Anne, Lee, Benhur, Baum, Linda G
• Format: Article
• Language: English
• Subjects: Encephalitis; Enzymes; Infections; Ligands; Mortality; Proteins; Viral infections
• ISSN: 1553-7366; 1553-7374
• DOI: 10.1371/journal.ppat.1000993

Nipah virus targets human endothelial cells via NiV-F and NiV-G envelope glycoproteins, resulting in endothelial syncytia formation and vascular compromise. Endothelial cells respond to viral infection by releasing innate immune effectors, including galectins, which are secreted proteins that bind to specific glycan ligands on cell surface glycoproteins. We demonstrate that galectin-1 reduces NiV-F mediated fusion of endothelial cells, and that endogenous galectin-1 in endothelial cells is sufficient to inhibit syncytia formation. Galectin-1 regulates NiV-F mediated cell fusion at three distinct points, including retarding maturation of nascent NiV-F, reducing NiV-F lateral mobility on the plasma membrane, and directly inhibiting the conformational change in NiV-F required for triggering fusion. Characterization of the NiV-F N-glycome showed that the critical site for galectin-1 inhibition is rich in glycan structures known to bind galectin-1. These studies identify a unique set of mechanisms for regulating pathophysiology of NiV infection at the level of the target cell.